Skip to main content
. 2022 May 19;12:8458. doi: 10.1038/s41598-022-12457-1

Figure 2.

Figure 2

Distribution of tumor fraction estimation. p0 Pos-neg vs. Pos-pos, p1 Pos-neg vs. Pos-pos Stage I, p2 Pos-neg vs. Pos-pos Stage II, p3 Pos-pos Stage I vs. Pos-pos Stage II. p-value: Student t-test, Pos-Neg Positive–negative subjects, Pos-Pos Positive-positive subjects.